Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2014PLoS MedicineOpen Access

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

A 2014 study studied this question.

synapsesocial.com/papers/6a9d69bf843eea9644fceb16https://doi.org/10.1371/journal.pmed.1001685
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data2013 · 116 citations
  2. 2First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children2011 · 919 citations
  3. 3A World Malaria Map: Plasmodium falciparum Endemicity in 20072009 · 515 citations
  4. 4Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine2011 · 107 citations
  5. 5Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection2009 · 541 citations